v3.24.1.u1
BALANCE SHEETS - USD ($)
Dec. 31, 2023
Dec. 31, 2022
CURRENT ASSETS    
Cash $ 96,391 $ 55,074
TOTAL CURRENT ASSETS 96,391 55,074
TOTAL ASSETS 96,391 55,074
CURRENT LIABILITIES    
Accounts payable and accrued expenses 4,620,925 2,993,920
Accrued compensation 645,947 221,875
Bridge loan, net of debt discount 316,324 435,630
Loan payable, net of debt discount 202,279
Loan payable - related party, net of debt discount 750,082 104,800
Due to Chromocell Corporation 5,386 5,386
TOTAL CURRENT LIABILITIES 6,540,943 3,761,611
TOTAL LIABILITIES 6,540,943 3,761,611
STOCKHOLDERS’  DEFICIT    
Common stock, $0.001 par value, 100,000,000 shares authorized, 3,914,338 and 1,111,112 shares issued and outstanding as of December 31, 2023 and 2022, respectively 391 111
Additional paid in capital 7,074,646 2,432,148
Accumulated / parent’s net deficit (13,519,649) (6,138,856)
TOTAL STOCKHOLDERS’ DEFICIT (6,444,552) (3,706,537)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 96,391 55,074
Series A Preferred Stock [Member]    
STOCKHOLDERS’  DEFICIT    
Preferred stock, value, issued 60 60
Series B Preferred Stock [Member]    
STOCKHOLDERS’  DEFICIT    
Preferred stock, value, issued
Series C Preferred Stock [Member]    
STOCKHOLDERS’  DEFICIT    
Preferred stock, value, issued

Source

HTML PDF
ZIP